Gini Fleming to Patient Safety
This is a "connection" page, showing publications Gini Fleming has written about Patient Safety.
Connection Strength
0.037
-
A Randomized Phase II Trial of Epigenetic Priming with Guadecitabine and Carboplatin in Platinum-resistant, Recurrent Ovarian Cancer. Clin Cancer Res. 2020 03 01; 26(5):1009-1016.
Score: 0.037